Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online March 20, 2008
Diabetes 57:1651-1658, 2008
DOI: 10.2337/db07-1761
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db07-1761v1
57/6/1651    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Liu, X.
Right arrow Articles by Egwuagu, C. E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, X.
Right arrow Articles by Egwuagu, C. E.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Suppressors of Cytokine-Signaling Proteins Induce Insulin Resistance in the Retina and Promote Survival of Retinal Cells

Xuebin Liu1, Marie G. Mameza1, Yun Sang Lee1, Chikezie I. Eseonu1,2, Cheng-Rong Yu1, Jennifer J. Kang Derwent3, and Charles E. Egwuagu1

1 Molecular Immunology Section, Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland
2 Department of Biomedical Engineering, Harvard College, Harvard University, Cambridge, Massachusetts
3 Department of Biomedical Engineering, Pritzker Institute of Biomedical Science and Engineering, Illinois Institute of Technology, Chicago, Illinois

Corresponding author: Dr. Charles E. Egwuagu, Molecular Immunology Section, Laboratory of Immunology, National Institutes of Health, Building 10, Rm. 10N116, 10 Center Dr., Bethesda, MD 20892-1857. E-mail: egwuaguc{at}nei.nih.gov

Abbreviations: EAU, experimental autoimmune uveitis; FOXO, forkhead transcription factor; GFP, green fluorescent protein; HIF, hypoxia-inducible factor; IFN, interferon; IL, interleukin; IRBP, interphotoreceptor retinoid binding protein; IRS, insulin receptor substrate; NIH, National Institutes of Health; PI3K, phosphatidylinositol 3-kinase; pSTAT, phosphorylated STAT; qRT-PCR, quantitative RT-PCR; RPA, ribonuclease protection assay; RGC, retinal ganglion cell; RPE, retinal pigment epithelium; siRNA, small interfering RNA; SOCS, suppressors of cytokine signaling; STAT, signal transducer and activator of transcription; STZ, streptozotocin; VEGF, vascular endothelial growth factor

OBJECTIVE—Suppressors of cytokine signaling (SOCS) are implicated in the etiology of diabetes, obesity, and metabolic syndrome. Here, we show that some SOCS members are induced, while others are constitutively expressed, in retina and examine whether persistent elevation of SOCS levels in retina by chronic inflammation or cellular stress predisposes to developing insulin resistance in retina, a condition implicated in diabetic retinopathy.

RESEARCH DESIGN AND METHODS—SOCS-mediated insulin resistance and neuroprotection in retina were investigated in 1) an experimental uveitis model, 2) SOCS1 transgenic rats, 3) insulin-deficient diabetic rats, 4) retinal cells depleted of SOCS6 or overexpressing SOCS1/SOCS3, and 5) oxidative stress and light-induced retinal degeneration models.

RESULTS—We show that constitutive expression of SOCS6 protein in retinal neurons may improve glucose metabolism, while elevated SOCS1/SOCS3 expression during uveitis induces insulin resistance in neuroretina. SOCS-mediated insulin resistance, as indicated by its inhibition of basally active phosphoinositide 3-kinase/AKT signaling in retina, is validated in retina-specific SOCS1 transgenic rats and retinal cells overexpressing SOCS1/SOCS3. We further show that the SOCS3 level is elevated in retina by oxidative stress, metabolic stress of insulin-deficient diabetes, or light-induced retinal damage and protects ganglion cells from apoptosis, suggesting that upregulation of SOCS3 may be a common physiologic response of neuroretinal cells to cellular stress.

CONCLUSIONS—Our data suggest two-sided roles of SOCS proteins in retina. Whereas SOCS proteins may improve glucose metabolism, mitigate deleterious effects of inflammation, and promote neuroprotection, persistent SOCS3 expression caused by chronic inflammation or cellular stress can induce insulin resistance and inhibit neurotrophic factors, such as ciliary neurotrophic factor, leukemia inhibitory factor, and insulin, that are essential for retinal cell survival.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.